methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]

RxCUI
1358619
RxNorm name
methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]
Display name
DEPO-Medrol (Injectable)
Full name
methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]
Term type
SBD
Status
Active
Strength
80 mg/ml
Dose form
Susp
Route
Injectable
Updated
2026-10-15 15:43:21

RxNorm Status History#

Status
Active
Source
RXNORM
Current
YES
Release start
122012
Active start
122012
Multiple ingredient
NO
Branded
YES

Ingredients And Strength#

Ingredient, Strength, Base table
IngredientStrengthBaseBasis of strength
methylprednisolone acetate80 MG / 1 MLmethylprednisolonemethylprednisolone acetate

Dose Form Concepts#

Dose form, RxCUI table
Dose formRxCUI
Injectable Suspension316950

Derived Ingredient Concepts#

Ingredient, RxCUI table
IngredientRxCUI
methylprednisolone6902

Source Vocabulary Codes#

Code type, Values, Count table
Code typeValuesCountCategory
PRESCRIBABLEY1ATTRIBUTES
RXNAV_STRDEPO-Medrol 80 MG/ML Injectable Suspension1NAMES
RxNorm Namemethylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol]1NAMES
RxNorm SynonymDepo-Medrol 80 MG/ML Injectable Suspension1NAMES
TTYSBD1ATTRIBUTES
SPL_SET_ID
2 linked values
2CODES
RxCUI13586191CODES
MMSL_CODEMTH_RXN_BD23141CODES

FDA NDC Products And Packages#

Package NDC, Product NDC, Name table
Package NDCProduct NDCNameLabelerApplication
0009-0306-020009-0306Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
0009-0306-120009-0306Depo-Medrol methylprednisolone acetatePharmacia & Upjohn Company LLCNDA011757
50090-1823-050090-1823DEPO-MEDROL methylprednisolone acetateA-S Medication SolutionsNDA011757

Drugs@FDA Applications#

Application, NDC, Name table
ApplicationNDCNameMarketing categoryLabeler
NDA0117570009-0306Depo-Medrol methylprednisolone acetateNDAPharmacia & Upjohn Company LLC

RxNav Current And Historical NDCs#

RxNav current and historical NDC rows page 1 of 1 · 23 matching rows.

NDC11, Source, Active table
NDC11SourceActive
00009030602rxnav_ndcsyes
00009030612rxnav_ndcsyes
50090182300rxnav_ndcsyes
00009030610rxnav_historical_indirect
00009030624rxnav_historical
00009347501rxnav_historical
00009347502rxnav_historical_indirect
00009347503rxnav_historical
00009347522rxnav_historical
00009347523rxnav_historical
00247125205rxnav_historical
35356048405rxnav_historical
54569223200rxnav_historical
54569337400rxnav_historical
54868118500rxnav_historical
54868118501rxnav_historical
55045324301rxnav_historical
55045324305rxnav_historical
55045380301rxnav_historical
55154393205rxnav_historical
58016993401rxnav_historical
61786002757rxnav_historical
70518214800rxnav_historical

UNII Substances#

UNII substance links page 1 of 1 · 0 matching rows.

No records found.

openFDA label cross-check#

OpenFDA label data provides additional search and identifier links. DailyMed’s Structured Product Label is the canonical label on FDA.report. Matching records are deduplicated before they are shown below.

Matched openFDA labels page 1 of 1 · 4 matching rows.

Brand, Generic, Manufacturer table
BrandGenericManufacturerSPL set IDEffective dateAvailable safety fieldsJoin
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLC823b0010-2b57-4e76-b5ac-4a8c2963438f2026-01-21Warnings, Adverse reactionsExact identifier
ndc (package): 0009-0306-02
ndc (package): 0009-0306-12
ndc (product): 0009-0306
ndc11 (package): 00009030612
ndc11 (package): 00009030602
rxcui: 1358619
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLC9a7b3837-e038-48bf-97e9-78ad463760dc2026-01-21Warnings, Adverse reactionsExact identifier
ndc11 (package): 00009347501
ndc11 (package): 00009347503
Depo-MedrolMETHYLPREDNISOLONE ACETATEPharmacia & Upjohn Company LLCbf1b104d-85cb-414d-a366-78068c82c8832025-12-01Warnings, Adverse reactionsExact identifier
ndc11 (package): 00009347522
ndc11 (package): 00009347523
DEPO-MEDROLMETHYLPREDNISOLONE ACETATEA-S Medication Solutionse8209047-c1e6-4081-a6d3-c603d9ee4f142025-10-27Warnings, Adverse reactionsExact identifier
ndc (package): 50090-1823-0
ndc (product): 50090-1823
ndc11 (package): 50090182300
rxcui: 1358619

Reported adverse events (FAERS/openFDA)#

Adverse event summaries are temporarily unavailable. Other product information remains available.

DailyMed RxNorm Mappings#

unique DailyMed labels mapped to this RxNorm concept page 1 of 1 · 3 matching rows.

Set ID, RxNorm mappings, Terms table
Set IDRxNorm mappingsTermsSPL versionLabelEffective
823b0010-2b57-4e76-b5ac-4a8c2963438fDEPO-Medrol 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] [SBD] · Depo-Medrol 80 MG/ML Injectable Suspension [SY]322DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)20260121
e8209047-c1e6-4081-a6d3-c603d9ee4f14DEPO-Medrol 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] [SBD] · Depo-Medrol 80 MG/ML Injectable Suspension [SY]314DEPO-MEDROL20251027
c5ca262e-5558-4065-8ef5-e2e76f3635e5DEPO-Medrol 80 MG/ML Injectable Suspension [PSN] · methylprednisolone acetate 80 MG/ML Injectable Suspension [Depo-Medrol] [SBD] · Depo-Medrol 80 MG/ML Injectable Suspension [SY]31DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USP20120201

Recently Linked DailyMed Labels#

Set ID, Title, Manufacturer table
Set IDTitleManufacturerEffective
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20260121
823b0010-2b57-4e76-b5ac-4a8c2963438fDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC20260121
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251217
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251201
823b0010-2b57-4e76-b5ac-4a8c2963438fDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC20251114
e8209047-c1e6-4081-a6d3-c603d9ee4f14DEPO-MEDROLA-S Medication Solutions20251027
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251008
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20251006
bf1b104d-85cb-414d-a366-78068c82c883DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC | Sterigenics Belgium Petit-Rechain S.A.20250828
9a7b3837-e038-48bf-97e9-78ad463760dcDEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia & Upjohn Company LLC20250818
69ca1281-55b7-426d-92e7-318414d7f226DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)REMEDYREPACK INC.20200406
43775cf1-4477-449a-e054-00144ff88e88ReadySharp Anesthetics + Methylprednisolone 80Terrain Pharmaceuticals20161209
cb33bed8-6f99-4a00-aa3a-c74e4f0a17e7DEPO-MEDROL ® (methylprednisolone acetate injectable suspension, USP)Pharmacia and Upjohn Company LLC20140124
95186b1b-cb0f-4091-86fe-c57d1d1e4986National Council for Prescription Drug Programs20120724
11505f08-dcaf-40aa-99cb-2d5714d90aefNational Council for Prescription Drug Programs20120724
b0d29b11-5614-4fb2-b45f-d19957d89fd7National Council for Prescription Drug Programs20120724
b9dc41a9-eb11-4db5-b0c1-2b0ec14cee04National Council for Prescription Drug Programs20120724
59d7e0c4-5d87-46ca-bbc9-351657b25dd5National Council for Prescription Drug Programs20120724
480595b6-0359-41f2-899f-4084cd256b20National Council for Prescription Drug Programs20120724
c5471b1d-6144-4774-ac4a-da96ba7e8495National Council for Prescription Drug Programs20120724
c5cab2df-bbc5-43e5-93e1-f4611d6eb481National Council for Prescription Drug Programs20120724
c5ca262e-5558-4065-8ef5-e2e76f3635e5DEPO-MEDROL ® methylprednisolone acetate injectable suspension, USPDispensing Solutions, Inc. | PSS World Medical, Inc.20120201

Drug Classes#

Source, Class ID, Class table
SourceClass IDClassTypeRelationshipDrug concept
ATCD10AACorticosteroids, combinations for treatment of acneATC1-4methylprednisolone
ATCD07AACorticosteroids, weak (group I)ATC1-4methylprednisolone
ATCH02ABGlucocorticoidsATC1-4methylprednisolone
FDASPLN0000175576CorticosteroidEPChas_epcmethylprednisolone
FDASPLN0000175450Corticosteroid Hormone Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTD008775MethylprednisoloneCHEMhas_ingredientmethylprednisolone
MEDRTD000077555Methylprednisolone AcetateCHEMhas_ingredientmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone acetate
MEDRTD000309Adrenal InsufficiencyDISEASEmay_treatmethylprednisolone
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone acetate
MEDRTD015210Arthritis, GoutyDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone
MEDRTD001172Arthritis, RheumatoidDISEASEmay_preventmethylprednisolone acetate
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone
MEDRTD001249AsthmaDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD001607BerylliosisDISEASEmay_treatmethylprednisolone
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone acetate
MEDRTD001932Brain NeoplasmsDISEASEmay_treatmethylprednisolone
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone acetate
MEDRTD003093Colitis, UlcerativeDISEASEmay_treatmethylprednisolone
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone acetate
MEDRTD003874Dermatitis HerpetiformisDISEASEmay_treatmethylprednisolone
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone acetate
MEDRTD003876Dermatitis, AtopicDISEASEmay_treatmethylprednisolone
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone acetate
MEDRTD004342Drug HypersensitivityDISEASEci_withmethylprednisolone
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone acetate
MEDRTD004892Erythema MultiformeDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone
MEDRTD006086Graft vs Host DiseaseDISEASEmay_treatmethylprednisolone acetate
MEDRTD006086Graft vs Host DiseaseDISEASEmay_preventmethylprednisolone acetate
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD006402Hematologic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone
MEDRTD006934HypercalcemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD007223InfantDISEASEci_withmethylprednisolone
MEDRTD007223InfantDISEASEci_withmethylprednisolone acetate
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone
MEDRTD007249InflammationDISEASEmay_treatmethylprednisolone acetate
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone
MEDRTD007938LeukemiaDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone acetate
MEDRTD008180Lupus Erythematosus, SystemicDISEASEmay_treatmethylprednisolone
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD009103Multiple SclerosisDISEASEmay_treatmethylprednisolone
MEDRTD009181MycosesDISEASEci_withmethylprednisolone acetate
MEDRTD009181MycosesDISEASEci_withmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone
MEDRTD009182Mycosis FungoidesDISEASEmay_treatmethylprednisolone acetate
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD009404Nephrotic SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone
MEDRTD009461Neurologic ManifestationsDISEASEmay_treatmethylprednisolone acetate
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone
MEDRTD010392PemphigusDISEASEmay_treatmethylprednisolone acetate
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone
MEDRTD012128Respiratory Distress SyndromeDISEASEmay_treatmethylprednisolone acetate
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone
MEDRTD012216Rheumatic DiseasesDISEASEmay_treatmethylprednisolone acetate
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone
MEDRTD012507SarcoidosisDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone acetate
MEDRTD012713Serum SicknessDISEASEmay_treatmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone
MEDRTD012874Skin Diseases, InfectiousDISEASEci_withmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone acetate
MEDRTD013167Spondylitis, AnkylosingDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone
MEDRTD013585SynovitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone acetate
MEDRTD013966ThyroiditisDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone
MEDRTD014397Tuberculosis, PulmonaryDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone acetate
MEDRTD014605UveitisDISEASEmay_treatmethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone
MEDRTN0000000159Glucocorticoid Receptor AgonistsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone acetate
MEDRTN0000000134Lipoxygenase InhibitorsMOAhas_moamethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000008327Carbohydrate Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone acetate
MEDRTN0000010253Decreased Capillary PermeabilityPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone
MEDRTN0000010248Decreased Fibroblast MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone acetate
MEDRTN0000008645Decreased Glucocorticoid SecretionPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone
MEDRTN0000008681Decreased Leukotriene ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone acetate
MEDRTN0000010246Decreased Polymorphonuclear Leukocyte MigrationPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone
MEDRTN0000008834Decreased Prostaglandin ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone acetate
MEDRTN0000008841Decreased Protein SynthesisPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone
MEDRTN0000009004Decreased Thromboxane ActivityPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone acetate
MEDRTN0000009739Lipid Metabolism AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone
MEDRTN0000009741Lysosomal Function AlterationPEhas_pemethylprednisolone acetate

Properties#

Category, Property, Value table
CategoryPropertyValue
ATTRIBUTESAVAILABLE_STRENGTH80 MG/ML (expressed as methylprednisolone acetate)
ATTRIBUTESGENERAL_CARDINALITYSINGLE
ATTRIBUTESHUMAN_DRUGUS
ATTRIBUTESRXNAV_HUMAN_DRUGUS
ATTRIBUTESSCHEDULE0
CODESNDANDA011757
NAMESPrescribable SynonymDEPO-Medrol 80 MG/ML Injectable Suspension
NAMESTallman SynonymDEPO-Medrol 80 MG/ML Injectable Suspension
NAMESTallman SynonymmethylPREDNISolone acetate 80 MG/ML Injectable Suspension [DEPO-Medrol]
SOURCESSourceGold Standard Alchemy
SOURCESSourceMetathesaurus FDA Structured Product Labels
SOURCESSourceMicromedex RED BOOK
SOURCESSourceMultum MediSource Lexicon